You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cytotoxic chemotherapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Non-Small Cell

Active, not recruiting
  • Stage I Lung Non-Small Cell Cancer AJCC v7
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 24, 2022

Sarcoma, Soft Tissue Trial in Worldwide (Nintedanib, Ifosfamide)

Terminated
  • Sarcoma, Soft Tissue
  • Brussels, Belgium
  • +12 more
Sep 10, 2021

Ovarian Cancer Trial in Worldwide (Alpelisib, Olaparib, Paclitaxel)

Recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +116 more
Nov 25, 2022

Nasopharyngeal Carcinoma Trial in Worldwide (autologous EBV specific Cytotoxic T cells, combination IV gemcitabine and IV

Active, not recruiting
  • Nasopharyngeal Carcinoma
  • autologous EBV specific Cytotoxic T cells
  • combination IV gemcitabine and IV carboplatin (AUC2)
  • Duarte, California
  • +29 more
Mar 5, 2021

Lymphoma Trial (Tislelizumab)

Not yet recruiting
  • Lymphoma
  • (no location specified)
Jul 28, 2022

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

Gastrointestinal Cancer, Gastrointestinal Tumors, Chemo-Induced Thrombocytopenia Trial in Miami, Boston (Avatrombopag, Matching

Not yet recruiting
  • Gastrointestinal Cancer
  • +2 more
  • Miami, Florida
  • +1 more
Mar 6, 2023

Stage III Colon Cancer Trial in France (Oxaliplatin, Oxaliplatin LBM)

Active, not recruiting
  • Stage III Colon Cancer
  • Marseille, Bouches Du Rhône, France
  • +10 more
Aug 2, 2022

Biliary Tract Tumors Trial in Seoul (Durvalumab, Tremelimumab, Gemcitabine)

Active, not recruiting
  • Biliary Tract Neoplasms
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 26, 2021

T-Cell and NK-Cell Tumor Trial

Not yet recruiting
  • T-Cell and NK-Cell Neoplasm
    • (no location specified)
    Sep 28, 2023

    Kaposi Sarcoma, Classic Kaposi Sarcoma, Refractory Kaposi Sarcoma Trial (Pembrolizumab + Lenvatinib)

    Not yet recruiting
    • Kaposi Sarcoma
    • +2 more
    • Pembrolizumab + Lenvatinib
    • (no location specified)
    Apr 27, 2023

    Cancer, Chemotherapeutic Agent Toxicity Trial in Santiago (Contigo Application)

    Not yet recruiting
    • Cancer
    • Chemotherapeutic Agent Toxicity
    • Contigo Application
    • Santiago, Chile
      Complejo Asistencial Dr. Sotero del Río
    Oct 10, 2023

    Metastatic Pancreatic Adenocarcinoma Trial (Avelumab and Pepinemab)

    Recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • Avelumab and Pepinemab
    • Rochester, New York
      University of Rochester Medical Center
    Jan 19, 2023

    Within 1st Week of Chemotherapy Using Diffuse Optical

    Withdrawn
    • Breast Cancer
    • Diffuse Optical Spectroscopy Imaging
    • Costa Mesa, California
    • +2 more
    Oct 28, 2022

    Pancreatic Adenocarcinoma Trial in Fairway (9-ING-41, Retifanlimab, Gemcitabine)

    Active, not recruiting
    • Pancreatic Adenocarcinoma
    • Fairway, Kansas
      Kansas University Cancer center
    Nov 2, 2022

    Malignant Pleural Mesothelioma, Chemo Effect Trial in Cairo (hyperthermic intrathoracic chemo)

    Recruiting
    • Malignant Pleural Mesothelioma
    • Chemotherapy Effect
    • hyperthermic intrathoracic chemotherapy
    • Cairo, Egypt
      Ain Shams University hospitals
    Aug 18, 2022

    Acute Myeloid Leukemia Trial in Baltimore, Houston (Atovaquone, Cytarabine, Daunorubicin)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Baltimore, Maryland
    • +1 more
    Oct 7, 2022

    Progressive Metastatic Prostate Cancer Trial in Worldwide (Enzalutamide, Placebo)

    Active, not recruiting
    Has Results
    • Progressive Metastatic Prostate Cancer
    • Beijing, China
    • +46 more
    Jan 13, 2023

    Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

    Not yet recruiting
    • Advanced Cancer
    • +16 more
    • Fosifloxuridine Nafalbenamide
    • +3 more
    • Birmingham, United Kingdom
    • +3 more
    Feb 1, 2023

    Mantle Cell Lymphoma, Non-hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Madison (Bendamustine, Obinutuzumab)

    Recruiting
    • Mantle Cell Lymphoma
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Sep 13, 2022

    MSI, dMMR Colorectal Cancer Trial in Paris (Monalizumab/MEDI5257)

    Not yet recruiting
    • MSI
    • dMMR Colorectal Cancer
    • Paris, France
      Department of medical oncology - Saint-Antoine Hospital
    Nov 28, 2023

    Breast Tumors Trial in Busan (Eflapegrastim)

    Not yet recruiting
    • Breast Neoplasms
    • Busan, Korea, Republic of
      Good Gang-An Hospital
    Jul 9, 2023

    Prostatic Tumor Trial (AAA617, AAA517, Piflufolastat F 18)

    Not yet recruiting
    • Prostatic Neoplasm
    • (no location specified)
    Apr 27, 2023

    Pancreas Cancer Trial in New York (Pembrolizumab, Azacitidine)

    Active, not recruiting
    • Pancreas Cancer
    • New York, New York
      Columbia University Irving Medical Center
    Nov 29, 2022

    Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive

    Active, not recruiting
    • Aggressive B-Cell Non-Hodgkin Lymphoma
    • fractionated first dose rituximab
    • Geneva, Switzerland
      University Hospital Geneva
    Apr 21, 2023